S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Rocket PharmaceuticalsI-MabGlobal Blood TherapeuticsOPKO HealthTaro Pharmaceutical Industries
SymbolNASDAQ:RCKTNASDAQ:IMABNASDAQ:GBTNASDAQ:OPKNYSE:TARO
Price Information
Current Price$52.42$49.28$40.96$4.22$74.52
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.81.31.41.90.9
Analysis Score3.53.53.43.51.5
Community Score2.93.23.02.52.2
Dividend Score0.00.00.00.00.0
Ownership Score2.50.00.01.70.0
Earnings & Valuation Score0.00.00.61.90.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$58.50$68.33$93.82$9.00$81.00
% Upside from Price Target11.60% upside38.66% upside129.06% upside113.27% upside8.70% upside
Trade Information
Market Cap$2.90 billion$3.55 billion$2.55 billion$2.83 billion$2.85 billion
Beta2.05N/A1.391.980.92
Average Volume473,056329,9241,103,4728,688,71331,664
Sales & Book Value
Annual RevenueN/A$4.31 million$2.11 million$901.90 million$644.77 million
Price / SalesN/A822.631,206.613.144.42
CashflowN/AN/AN/AN/A$6.72 per share
Price / CashN/AN/AN/AN/A11.09
Book Value$6.10 per share$3.34 per share$9.61 per share$2.43 per share$55.15 per share
Price / BookN/A14.754.261.741.35
Profitability
Net Income$-77,270,000.00$-208,560,000.00$-266,770,000.00$-314,920,000.00$244.24 million
EPS($1.58)($28.90)($4.71)($0.41)$6.35
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/A70.3317.79
P/E GrowthN/AN/AN/A5.84N/A
Net MarginsN/AN/A-332.94%-9.79%-45.94%
Return on Equity (ROE)-35.81%N/A-56.43%-2.61%10.36%
Return on Assets (ROA)-27.52%N/A-39.32%-1.80%8.38%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.25%N/A0.16%0.13%N/A
Current Ratio7.30%N/A7.63%1.27%2.53%
Quick Ratio7.30%N/A7.20%0.94%2.25%
Ownership Information
Institutional Ownership PercentageN/A16.64%N/A28.51%11.23%
Insider Ownership Percentage41.40%N/A4.30%40.90%13.80%
Miscellaneous
Employees842293526,0961,464
Shares Outstanding55.23 million71.95 million62.16 million670.04 million38.26 million
Next Earnings Date5/5/2021 (Estimated)3/29/2021 (Confirmed)5/5/2021 (Estimated)5/5/2021 (Estimated)5/18/2021 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.